PH vs EMR
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Jul 29, 2026
PH
60.1
AI Score
VS
PH Wins
EMR
50.3
AI Score
Investment Advisor Scores
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | PH | EMR | Winner |
|---|---|---|---|
| Revenue | 15.74B | 8.91B | PH |
| Net Income | 2.56B | 1.22B | PH |
| Net Margin | 16.2% | 13.7% | PH |
| ROE | 17.5% | 6.0% | PH |
| ROA | 8.3% | 2.9% | PH |
| Total Assets | 30.68B | 42.09B | EMR |
| Current Ratio | 1.13 | 0.87 | PH |
| Free Cash Flow | 2.34B | 1.30B | PH |
Relative Price Performance (Last 90 Days)
PH 1M: +3.1%
· 3M: +12.5%
EMR 1M: +10.9%
· 3M: +12.2%
Current Technical Phase
PH
MarkupHold / add on dips
Price above SMA50, rising 50-day trend (2.9% over 20 days), RSI 60
EMR
MarkupHold / add on dips
Price above SMA50, rising 50-day trend (1.2% over 20 days), RSI 65
Fundamentals Snapshot
| Metric | PH | EMR |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 29.2 | 21.6 |
| Trailing P/E | 36.0 | 34.8 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.0% |
| Gross Margin | 0.4% | 0.5% |
| Operating Margin | 0.2% | 0.2% |
| EPS | 27.15 | 4.31 |
| Dividend Yield | 0.01% | 0.01% |
Frequently Asked Questions
Based on our detailed analysis, PH is currently the stronger investment candidate, winning 7 of the key financial metrics based on our comprehensive scoring model.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.